By the Peptevity Research Desk — vendor-neutral, evidence-graded. Scientific review: independent reviewer pending — how our review works.

Bacteriostatic Water: The Reconstitution Diluent, Explained

Direct answer

Bacteriostatic Water for Injection, USP is sterile water with 0.9% (9 mg/mL) benzyl alcohol added as a bacteriostatic preservative — the diluent most often named in peptide reconstitution procedures (DailyMed label). The preservative is the whole point: it suppresses microbial growth so a vial can be punctured more than once, unlike single-dose Sterile Water for Injection, which carries no preservative. It is not saline — it contains no sodium chloride — and it is hypotonic, so it is used to dilute or dissolve other agents, not injected alone. Its label carries a prominent warning, "NOT FOR USE IN NEONATES," because benzyl alcohol has been linked to fatal "gasping syndrome" in newborns (NEJM, 1982). This page is research and educational information, not medical advice, and describes laboratory diluent chemistry — not a human-use protocol. Peptevity sells nothing.

What bacteriostatic water is

Bacteriostatic Water for Injection, USP is exactly what the name says: water for injection plus a preservative. The preservative is benzyl alcohol at 0.9% — 9 mg/mL — and the finished solution is sterile, nonpyrogenic, and mildly acidic, with a labeled pH of about 5.7 (range 4.5 to 7.0) (DailyMed label). It contains no electrolytes — no sodium chloride, no buffer salts — which is the single fact that most often gets confused, because people assume "water for injection" and "saline" are interchangeable. They are not.

In a laboratory reconstitution procedure, bacteriostatic water serves one function: it is the diluent that returns a lyophilized (freeze-dried) peptide powder to solution at a known concentration. We describe that procedure, and the framing it holds, on how to reconstitute peptides and in the peptide reconstitution chart. This page is about the diluent itself — what is in it, what it is not, and the one warning on its label that matters most.

The "bacteriostatic" descriptor is precise. Benzyl alcohol is a bacteriostatic agent — it inhibits bacterial growth — rather than a bactericidal one that actively kills organisms. That distinction is why the label still imposes time limits on a punctured vial: the preservative holds microbial growth in check, it does not sterilize a contaminated solution.

Why the preservative enables a multi-use vial

The preservative is the entire reason bacteriostatic water exists as a separate product from plain sterile water. Each time a needle pierces a vial's stopper, it creates an opportunity for microbial contamination. In a preservative-free single-dose vial, there is nothing to suppress any organism introduced that way, so the standard is to use the contents once and discard the rest. The benzyl alcohol in bacteriostatic water suppresses that growth, which is what makes a multiple-dose vial practical — the vial can be entered more than once over a limited window rather than thrown away after a single use (DailyMed label).

That convenience is bounded, not unlimited. Manufacturer labeling and USP convention for multiple-dose containers set a finite in-use window after first puncture (commonly cited as up to 28 days for preserved multi-dose vials, refrigerated, absent a shorter manufacturer limit), and label directions govern in any specific case (DailyMed label). The preservative buys repeated access; it does not make the vial — or anything dissolved in it — chemically immortal.

One caveat carries straight into research formulation. Benzyl alcohol is not inert toward peptides and proteins. In formulation work it can promote aggregation by interacting with nonpolar (hydrophobic) side chains, which is one reason highly hydrophobic peptides are sometimes handled with a different diluent strategy rather than bacteriostatic water alone (Factors affecting peptide aggregation, 2017, PMC5665799). The same molecule that protects the vial from microbes can, in the wrong context, destabilize the solute — a trade-off worth knowing on the bench.

How it differs from Sterile Water for Injection and from saline

These three liquids look identical in the vial and are routinely conflated. They are chemically distinct, and the differences are on their FDA-regulated labels.

Property Bacteriostatic Water for Injection Sterile Water for Injection 0.9% Sodium Chloride (saline)
Preservative 0.9% benzyl alcohol (9 mg/mL) None None (in plain 0.9% NaCl)
Electrolytes None None Sodium chloride, 9 mg/mL
Vial type Multiple-dose Single-dose Single- or multiple-dose (formulation-dependent)
Tonicity Hypotonic Hypotonic Isotonic
Neonate use Labeled "NOT FOR USE IN NEONATES" Preferred preservative-free option for neonates —
Primary labeled purpose Diluting/dissolving drugs (multi-use) Diluting/dissolving drugs (single use) Fluid/electrolyte vehicle; diluent

Sources: DailyMed — Bacteriostatic Water.

Versus Sterile Water for Injection (SWFI): SWFI contains "no bacteriostat, antimicrobial agent or added buffer" and is packaged single-dose — so it must be used promptly and the remainder discarded (DailyMed label). The only meaningful difference is the preservative: bacteriostatic water trades a small additive (benzyl alcohol) for repeated-access convenience. Where a preservative is undesirable — neonates being the explicit case — preservative-free SWFI is the substitute.

Versus saline (0.9% sodium chloride): Saline is isotonic because it carries sodium chloride at 9 mg/mL, roughly matching the osmolarity of blood. Bacteriostatic water carries no salt and is hypotonic. That tonicity gap matters: the bacteriostatic water label explicitly warns that intravenous administration of the diluent without a solute may result in hemolysis (rupture of red blood cells), and that any admixture should be made approximately isotonic before use (DailyMed label). In other words, neither water product is meant to be injected on its own — they are vehicles for something else.

The "NOT FOR USE IN NEONATES" warning and benzyl alcohol "gasping syndrome"

The most important line on the bacteriostatic water label is its prominent warning: "NOT FOR USE IN NEONATES." The label is explicit about why — benzyl alcohol, the preservative, has been associated with toxicity in neonates — and directs that, where water is needed to prepare or dilute medications for neonates, only preservative-free Sterile Water for Injection should be used (DailyMed label).

The warning traces to a specific clinical event. In November 1982, The New England Journal of Medicine published Gershanik and colleagues' report describing a cluster of ten premature infants in a neonatal intensive care unit who developed a fatal syndrome — progressive metabolic acidosis, a characteristic gasping respiration, neurological deterioration, and cardiovascular collapse — traced to benzyl alcohol in the flush solutions and diluents used in their care (Gershanik et al., N Engl J Med 1982;307(22):1384–8). The pattern became known as "gasping syndrome." Earlier in 1982, the FDA, the American Academy of Pediatrics, and the CDC had already issued advisories warning against benzyl-alcohol-preserved fluids and diluents in newborns (Lovejoy, Am J Dis Child 1982;136(11):974–5).

This is the one place on the page where a safety signal is concrete and well-documented, and it is worth stating plainly rather than as a blanket scare: the toxicity concern is specific to neonates and to the benzyl alcohol preservative, driven by the immature capacity of newborns to metabolize benzyl alcohol's breakdown products at the exposures seen in intensive-care settings. It is the reason the preserved product is contraindicated in that population and the unpreserved product is the substitute. It is not a claim about peptide use in adults, which sits outside this page's scope.

Where bacteriostatic water sits in a reconstitution procedure

In the laboratory, bacteriostatic water is the default diluent for aqueous-soluble peptides — the powder is dissolved in a measured volume of it, and concentration is computed as milligrams of peptide divided by milliliters of diluent. That math and the gentle-handling mechanics (direct the diluent against the glass wall, swirl rather than shake) are covered on how to reconstitute peptides, with worked tables on the peptide reconstitution chart and the arithmetic automated by the peptide calculator.

Two procedural notes are specific to the diluent. First, solubility is set by the peptide's sequence, not by the water — peptides rich in charged, hydrophilic residues generally dissolve readily in aqueous diluent, whereas highly hydrophobic peptides may be only partly soluble and are sometimes taken up first in a small amount of an organic co-solvent before dilution, per manufacturer technical notes (Bachem, peptide solubility technical note). Second, once a peptide is in solution the stability clock starts — solution is less stable than the dry lyophilized powder, and temperature, light, and time become the governing variables, which is why the storage discussion lives on how to store peptides (PMC5665799). The benzyl alcohol that keeps the vial multi-use does nothing to slow degradation of the solute itself.

Everything above describes a bench technique. Whether the substance dissolved is something a person should ever receive is a separate question this page does not answer: the peptides usually involved are not FDA-approved, are sold "research use only — not for human consumption," and sit in a regulatory picture that is actively shifting through 2026 and into 2027. For what that label means, see what "research use only" means and whether peptides are legal.

Honest bottom line

Bacteriostatic water is plain sterile water plus 0.9% benzyl alcohol — and that one additive defines everything about it. The preservative is what makes a multi-use vial possible, which is why it shows up in reconstitution procedures rather than single-dose Sterile Water for Injection. It is not saline: it carries no salt, it is hypotonic, and its own label warns it should not be injected without a solute. The additive that protects the vial also carries the page's single hard safety fact — the labeled "NOT FOR USE IN NEONATES" warning, grounded in the 1982 benzyl-alcohol "gasping syndrome" reports. All of that is diluent chemistry and FDA labeling, sourced to primary records. What it is not is a green light to prepare anything for a human body — that line, between the diluent (well defined) and the use (not something we instruct), is the one to hold. For the dated status of the peptides involved, watch the living 2026 regulatory tracker.

Frequently asked questions

What is bacteriostatic water? Bacteriostatic Water for Injection, USP is sterile water containing 0.9% (9 mg/mL) benzyl alcohol as a bacteriostatic preservative, with a labeled pH around 5.7 (DailyMed). It is an Rx-only parenteral preparation indicated only for diluting or dissolving drugs for IV, IM, or SC injection — a vehicle, not a treatment. This is research and educational information, not medical advice.

How is bacteriostatic water different from Sterile Water for Injection? The difference is the preservative. Sterile Water for Injection contains no bacteriostat, antimicrobial agent, or buffer and is single-dose, so it must be used once and discarded; bacteriostatic water adds 0.9% benzyl alcohol so the vial can be entered more than once over a limited window (DailyMed). For neonates, only preservative-free Sterile Water for Injection should be used.

Is bacteriostatic water the same as saline? No. Saline is 0.9% sodium chloride and is isotonic; bacteriostatic water contains no salt and is hypotonic. The bacteriostatic water label warns that intravenous administration without a solute may cause hemolysis and that admixtures should be made approximately isotonic before use, so it is a diluent, not a standalone injection fluid (DailyMed).

Why does the preservative allow a multi-use vial? Each needle puncture risks introducing microbes; benzyl alcohol is a bacteriostatic agent that suppresses bacterial growth, so a preserved vial can be entered repeatedly over a finite in-use window rather than discarded after one use (DailyMed). It inhibits growth — it does not sterilize an already-contaminated solution, and label time limits still apply.

Why is bacteriostatic water labeled "NOT FOR USE IN NEONATES"? Because benzyl alcohol has been associated with fatal toxicity in newborns. A 1982 New England Journal of Medicine report described ten premature infants who developed a fatal "gasping syndrome" — metabolic acidosis, gasping respirations, neurological deterioration, and cardiovascular collapse — linked to benzyl-alcohol-preserved fluids (Gershanik et al., NEJM 1982). The label therefore directs preservative-free Sterile Water for Injection for neonates (DailyMed).

Can benzyl alcohol affect the peptide being reconstituted? It can. In peptide and protein formulation, benzyl alcohol can promote aggregation by interacting with hydrophobic side chains, which is one reason highly hydrophobic peptides are sometimes handled with a different diluent strategy (PMC5665799). The same additive that protects the vial can destabilize certain solutes — a bench trade-off, described here as laboratory chemistry, not a use instruction.

How we graded this page

This is a procedural/laboratory explainer about a diluent, not an efficacy claim. Every composition, labeling, and safety statement is tied to a primary or regulator source — FDA labeling via DailyMed, the peer-reviewed NEJM report, and manufacturer/peer-reviewed formulation literature — per our evidence-grading methodology and sourcing and citation policy. Peptevity carries no advertising, no affiliate links, and sells nothing — see our conflict-of-interest and funding statement and our medical disclaimer and RUO statement.

References

Related on Peptevity

External references appear as citations only; none of the cited institutions endorse, review, or are affiliated with Peptevity.

Every claim above is cited inline to a primary source. See how we grade evidence and our sourcing & citation policy.